Israel Englander’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$63.9M Buy
132,300
+90,500
+217% +$24M 0.02% 744
2026
Q1
$4.58M Sell
41,800
-191,700
-82% -$27.3M ﹤0.01% 3048
2025
Q4
$38.8M Buy
233,500
+51,400
+28% +$8.6M 0.02% 990
2025
Q3
$35.7M Buy
182,100
+69,000
+61% +$11.3M 0.02% 1116
2025
Q2
$10.2M Sell
113,100
-16,900
-13% -$1.34M ﹤0.01% 2231
2025
Q1
$7.76M Buy
130,000
+122,200
+1,567% +$11.3M ﹤0.01% 2440
2024
Q4
$1.03M Sell
7,800
-59,000
-88% -$5.54M ﹤0.01% 4175
2024
Q3
$3.5M Buy
+66,800
New +$3.14M ﹤0.01% 3169

Other funds holding ALAB

Israel Englander's ALAB Position: Q2 2026 in Review

Israel Englander increased its Astera Labs (ALAB) stake by 174% in Q2 2026, buying an estimated $102M and bringing the position to 604,489 shares worth $292M. The position accounts for 0.11% of the portfolio, ranked #147.

Israel Englander first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 984 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Israel Englander held 604,489 shares of Astera Labs worth $292M as of Q2 2026.
  • Israel Englander bought 384,082 Astera Labs shares in Q2 2026, an estimated $102M.
  • Astera Labs made up 0.11% of Israel Englander's portfolio in Q2 2026, its #147 holding.
  • Israel Englander first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 984 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.